|
| Title |
|
|
|
Efficient and non-genotoxic RNA-based engineering of human T cells using tumor-specific T cell receptors with minimal TCR mispairing
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Frontiers in immunology. - Place of publication unknown | |
| Publication |
|
|
|
Place of publication unknown : 2018
| |
| ISSN |
|
|
|
1664-3224
| |
| Volume/pages |
|
|
|
9(2018), 14 p.
| |
| Article Reference |
|
|
|
2503
| |
| ISI |
|
|
|
000449420000001
| |
| Pubmed ID |
|
|
|
30464762
| |
| Medium |
|
|
|
E-only publicatie
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|
| Faculty/Department |
|
|
| | |
| Research group |
|
|
|
| Project info |
|
|
|
Improved RNA-based engineering of T lymphocytes with leukemia-specific T cell receptors to redirect their effector functions: towards a clinically safe platform to evaluate efficacy and potential off-target toxicity.
| Publication type |
|
|
| | | |
| Subject |
|
|
| | | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
22.10.2018
|
|
| Last edited |
|
| |
16.03.2021
|
|
| To cite this reference |
|
|
| | |
|
| |